National Institute on Aging; Notice of Meeting, 56395-56396 [2024-14968]

Download as PDF Federal Register / Vol. 89, No. 131 / Tuesday, July 9, 2024 / Notices bio, and letter of endorsement should all be submitted at the same time. The résumé or bio must provide examples and descriptions of relevant activities and experiences related to the applicant’s qualifications for PEC membership. The letter of endorsement should emphasize information relevant to the criteria for membership described above. This letter must be from and written by someone other than yourself. The letter may address topics such as the applicant’s involvement in patient advocacy activities, experiences that stimulated an interest in participating in discussions about patient engagement in medical product development and regulatory decision processes, and other information that may be helpful in evaluating the applicant’s qualifications as a potential member of the PEC. Applications will be accepted until 11:59 p.m. Eastern Time on August 8, 2024 or until 75 applications are received, whichever happens first. Only complete applications will be considered. The application review period will take a minimum of 2 months after 11:59 p.m. Eastern Time on August 8, 2024. Additional information may be needed from some applicants during the review period, including information relevant to understanding potential sources of conflict of interest, in which case applicants will be contacted directly. All applicants (both those selected for PEC membership and those who are not selected) will be notified by email of the final application decision no later than December 31, 2024. Dated: July 3, 2024. Lauren K. Roth, Associate Commissioner for Policy. [FR Doc. 2024–15008 Filed 7–8–24; 8:45 am] Statutory Authority The Indian Health Service (IHS) is accepting applications for the second round of cooperative agreement for the Ending the Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), and Syphilis Epidemics (known as ‘‘the Syndemic’’) in Indian Country (ETHIC II) program. This program is authorized under the Snyder Act, 25 U.S.C. 13; the Transfer Act, 42 U.S.C. 2001(a); and the Indian Health Care Improvement Act, 25 U.S.C. 1621q, 1660e. The Assistance Listings section of SAM.gov (https:// sam.gov/content/home) describes this program under 93.933. Purpose The purpose of this program is to support communities to directly increase the diagnoses, treatment, and prevention of HIV, HCV, and syphilis. The full Notice of Funding Opportunity and all application materials can be found on Grants.gov at https://grants.gov/search-results-detail/ 355020. II. Award Information Funding Instrument—Cooperative Agreement Estimated Funds Available The total funding identified for fiscal year (FY) 2024 is approximately $14 million. Individual award amounts are anticipated to be between $150,000 and $2,000,000. Period of Performance The period of performance is for 5 years. Indian Health Service Funding Opportunity for Ending the HIV/HCV/Syphilis Epidemics in Indian Country II (ETHIC II): A Syndemic Elimination Program for American Indian/Alaska Native Tribes and Urban Indian Communities lotter on DSK11XQN23PROD with NOTICES1 I. Funding Opportunity Description The IHS anticipates issuing approximately 26 awards under this program announcement. DEPARTMENT OF HEALTH AND HUMAN SERVICES Announcement Type: New. Funding Announcement Number: HHS–2024–IHS–ETHIC–0001. Assistance Listing (Catalog of Federal Domestic Assistance or CFDA) Number: 93.933. 18:00 Jul 08, 2024 Application Deadline Date: July 31, 2024. Earliest Anticipated Start Date: September 1, 2024. Anticipated Number of Awards BILLING CODE 4164–01–P VerDate Sep<11>2014 Key Dates Jkt 262001 III. Eligibility Information 1. Eligibility To be eligible for this funding opportunity an applicant must be one of the following, as defined by 25 U.S.C. 1603: • A federally recognized Indian Tribe as defined by 25 U.S.C. 1603(14). • A Tribal organization as defined by 25 U.S.C. 1603(26). • An Urban Indian organization, as defined by 25 U.S.C. 1603(29). PO 00000 Frm 00120 Fmt 4703 Sfmt 4703 56395 IV. Agency Contacts 1. Questions on the program matters may be directed to: Rick Haverkate, HIV/HCV/STI Branch, 5600 Fishers Lane, 08N07, MAIL STOP: 08N34–A, Rockville, MD 20857, Phone: 240–678–2873, Fax: 301–594–6213, Email: Richard.Haverkate@ihs.gov. 2. Questions on awards management and fiscal matters may be directed to: Indian Health Service, Division of Grants Management, 5600 Fishers Lane, Mail Stop: 09E70, Rockville, MD 20857, Email: DGM@ihs.gov. 3. For technical assistance with Grants.gov, please contact the Grants.gov help desk at (800) 518–4726, or by email at support@grants.gov. 4. For technical assistance with GrantSolutions, please contact the GrantSolutions help desk at (866) 577– 0771, or by email at help@ grantsolutions.gov. V. Other Information The Public Health Service strongly encourages all grant, cooperative agreement, and contract recipients to provide a smoke-free workplace and promote the non-use of all tobacco products. In addition, Public Law 103– 227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of the facility) in which regular or routine education, library, day care, health care, or early childhood development services are provided to children. This is consistent with the HHS mission to protect and advance the physical and mental health of the American people. Roselyn Tso, Director, Indian Health Service. [FR Doc. 2024–14963 Filed 7–8–24; 8:45 am] BILLING CODE 4166–14–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Board of Scientific Counselors, NIA. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should E:\FR\FM\09JYN1.SGM 09JYN1 56396 Federal Register / Vol. 89, No. 131 / Tuesday, July 9, 2024 / Notices lotter on DSK11XQN23PROD with NOTICES1 notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended for the review, discussion, and evaluation of individual grant applications conducted by the National Institute On Aging, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors, NIA Board of Scientific Counselors, NIA. Date: October 22–24, 2024. Closed: October 22, 2024, 8:00 a.m. to 8:45 a.m. Agenda: Executive Session; Opening Remarks (Richard J. Hodes, M.D., NIA Director, and Luigi Ferrucci, M.D., Ph.D., Scientific Director, NIA); Board Business (Holly M. Brown-Borg, Ph.D., Acting Chairperson). Place: National Institutes of Health, Biomedical Research Center, 3C211/Virtual, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Open: October 22, 2024, 8:45 a.m. to 11:30 a.m. Agenda: Translational Gerontology Branch Overview (Rafael de Cabo, Ph.D., Laboratory Chief, Senior Investigator, TGB Reviewers); Discussion; (Robert Brosh, Ph.D., Senior Investigator, TGB Reviewers); Discussion; Break; (Natan Basisty, Ph.D., NIH Distinguished Investigator, Tenure-Track Investigator, Translational Gerontology Branch); Discussion. Place: National Institutes of Health, Biomedical Research Center, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Closed: October 22, 2024, 11:30 a.m. to 2:00 p.m. Agenda: Drs. de Cabo, Brosh, and Basisty meet individually and privately with BSC members; Break; Executive Session Luncheon. Place: National Institutes of Health, Biomedical Research Center, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Open: October 22, 2024, 2:00 p.m. to 4:00 p.m. Agenda: (Isabel Beerman, Ph.D., Earl Stadtman Tenure-Track Investigator, Translational Gerontology Branch Reviewers); Discussion (Rafael de Cabo, Ph.D., Senior Investigator, Translational Gerontology Branch Reviewers); Discussion. Place: National Institutes of Health, Biomedical Research Center, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Closed: October 22, 2024, 4:00 p.m. to 6:00 p.m. Agenda: Drs. Beerman and de Cabo meet individually and privately with BSC members; Break; Executive Session; Adjourn. VerDate Sep<11>2014 18:00 Jul 08, 2024 Jkt 262001 Place: National Institutes of Health, Biomedical Research Center, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Closed: October 23, 2024, 8:00 a.m. to 8:30 a.m. Agenda: Executive Session; Opening Remarks (Richard J. Hodes, M.D., NIA Director, and Luigi Ferrucci, M.D., Ph.D., Scientific Director, NIA); Board Business (Holly M. Brown-Borg, Ph.D., Acting Chairperson). Place: National Institutes of Health, Biomedical Research Center, 3C211/Virtual, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Open: October 23, 2024, 8:30 a.m. to 11:30 a.m. Agenda: (Julie Mattison, Ph.D., Staff Scientist 2 (Facility Head), Translational Gerontology Branch Reviewers); Discussion; (Baltimore Longitudinal Study of Aging) (Eleanor Simonsick, Ph.D., Epidemiologist, Translational Gerontology Branch Reviewers); Discussion; Break; Title (Nigel Greig, Ph.D., Senior Investigator, Translational Gerontology Branch Reviewers); Discussion). Place: National Institutes of Health, Biomedical Research Center, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Closed: October 23, 2024, 11:30 a.m. to 1:30 p.m. Agenda: Drs. Mattison, Simonsick, and Greig meet individually and privately with BSC members; Executive Session Luncheon. Place: National Institutes of Health, Biomedical Research Center, 3A519/Virtual, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Open: October 23, 2024, 1:30 p.m. to 2:30 p.m. Agenda: (Luigi Ferrucci, M.D., Senior Investigator, Translational Gerontology Branch Reviewers); Discussion. Place: National Institutes of Health, Biomedical Research Center, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Closed: October 23, 2024, 2:30 p.m. to 6:00 p.m. Agenda: Dr. Ferrucci meets individually and privately with BSC members; Break; Laboratory/Branch Leadership Overview (Rafael del Cabo, Ph.D., Laboratory Chief, Senior Investigator, Translational Gerontology Branch Discussion Leader); Discussion with the Laboratory/Branch Chief; Leadership Review Discussion; Break; BSC members to meet with Fellows from Laboratory of Behavioral Neuroscience; Executive Session; Adjourn. Place: National Institutes of Health, Biomedical Research Center, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Closed: October 24, 2024, 8:00 a.m. to 8:30 a.m. Agenda: Executive Session; Opening Remarks (Richard J. Hodes, M.D., NIA Director, and Luigi Ferrucci, M.D., Ph.D., Scientific Director, NIA); Board Business (Holly Brown-Borg, Ph.D., Acting Chairperson). Place: National Institutes of Health, Biomedical Research Center, 3C211/Virtual, PO 00000 Frm 00121 Fmt 4703 Sfmt 4703 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Open: October 24, 2024, 8:30 a.m. to 10:15 a.m. Agenda: (AD Concept) (Luigi Ferrucci, M.D., Ph.D., Senior Investigator, Translational Gerontology Branch Reviewer); Discussion; (AD Concept) (Keenan Walker, Ph.D., NIH Distinguished Scholar, Tenuretrack Investigator of Behavioral Neurosciences Reviewers); Discussion; (AD R&D Concept) (Mustapha Bouhrara, Ph.D., Earl Stadtman Tenure-Track Investigator, Laboratory of Clinical Investigator Reviewers); Discussion; Break. Place: National Institutes of Health, Biomedical Research Center, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Closed: October 24, 2024, 10:15 a.m. to 11:30 a.m. Agenda: Executive Session Luncheon; Adjourn. Place: National Institutes of Health, Biomedical Research Center, 3A519/Virtual, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual Meeting). Contact Person: Luigi Ferrucci, M.D., Ph.D., Scientific Director, National Institute on Aging, 251 Bayview Boulevard, Suite 100, Room 4C225, Baltimore, MD 21224, 410– 558–8110, LF27Z@NIH.GOV. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: July 2, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–14968 Filed 7–8–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory General Medical Sciences Council. The meeting will be held as a virtual meeting and open to the public, as indicated below. Individuals who plan to view the virtual meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should submit a request using the following link: https:// www.nigms.nih.gov/Pages/ ContactUs.aspx at least 5 days prior to the event. The open session will also be videocast, closed captioned, and can be accessed from the NIH Videocasting and Podcasting website (https:// videocast.nih.gov). The meeting will be closed to the public in accordance with the E:\FR\FM\09JYN1.SGM 09JYN1

Agencies

[Federal Register Volume 89, Number 131 (Tuesday, July 9, 2024)]
[Notices]
[Pages 56395-56396]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-14968]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Aging; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Board of Scientific 
Counselors, NIA.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should

[[Page 56396]]

notify the Contact Person listed below in advance of the meeting.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in sections 552b(c)(4) and 
552b(c)(6), title 5 U.S.C., as amended for the review, discussion, and 
evaluation of individual grant applications conducted by the National 
Institute On Aging, including consideration of personnel qualifications 
and performance, and the competence of individual investigators, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Board of Scientific Counselors, NIA Board of 
Scientific Counselors, NIA.
    Date: October 22-24, 2024.
    Closed: October 22, 2024, 8:00 a.m. to 8:45 a.m.
    Agenda: Executive Session; Opening Remarks (Richard J. Hodes, 
M.D., NIA Director, and Luigi Ferrucci, M.D., Ph.D., Scientific 
Director, NIA); Board Business (Holly M. Brown-Borg, Ph.D., Acting 
Chairperson).
    Place: National Institutes of Health, Biomedical Research 
Center, 3C211/Virtual, 251 Bayview Boulevard, Baltimore, MD 21224 
(Virtual Meeting).
    Open: October 22, 2024, 8:45 a.m. to 11:30 a.m.
    Agenda: Translational Gerontology Branch Overview (Rafael de 
Cabo, Ph.D., Laboratory Chief, Senior Investigator, TGB Reviewers); 
Discussion; (Robert Brosh, Ph.D., Senior Investigator, TGB 
Reviewers); Discussion; Break; (Natan Basisty, Ph.D., NIH 
Distinguished Investigator, Tenure-Track Investigator, Translational 
Gerontology Branch); Discussion.
    Place: National Institutes of Health, Biomedical Research 
Center, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual 
Meeting).
    Closed: October 22, 2024, 11:30 a.m. to 2:00 p.m.
    Agenda: Drs. de Cabo, Brosh, and Basisty meet individually and 
privately with BSC members; Break; Executive Session Luncheon.
    Place: National Institutes of Health, Biomedical Research 
Center, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual 
Meeting).
    Open: October 22, 2024, 2:00 p.m. to 4:00 p.m.
    Agenda: (Isabel Beerman, Ph.D., Earl Stadtman Tenure-Track 
Investigator, Translational Gerontology Branch Reviewers); 
Discussion (Rafael de Cabo, Ph.D., Senior Investigator, 
Translational Gerontology Branch Reviewers); Discussion.
    Place: National Institutes of Health, Biomedical Research 
Center, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual 
Meeting).
    Closed: October 22, 2024, 4:00 p.m. to 6:00 p.m.
    Agenda: Drs. Beerman and de Cabo meet individually and privately 
with BSC members; Break; Executive Session; Adjourn.
    Place: National Institutes of Health, Biomedical Research 
Center, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual 
Meeting).
    Closed: October 23, 2024, 8:00 a.m. to 8:30 a.m.
    Agenda: Executive Session; Opening Remarks (Richard J. Hodes, 
M.D., NIA Director, and Luigi Ferrucci, M.D., Ph.D., Scientific 
Director, NIA); Board Business (Holly M. Brown-Borg, Ph.D., Acting 
Chairperson).
    Place: National Institutes of Health, Biomedical Research 
Center, 3C211/Virtual, 251 Bayview Boulevard, Baltimore, MD 21224 
(Virtual Meeting).
    Open: October 23, 2024, 8:30 a.m. to 11:30 a.m.
    Agenda: (Julie Mattison, Ph.D., Staff Scientist 2 (Facility 
Head), Translational Gerontology Branch Reviewers); Discussion; 
(Baltimore Longitudinal Study of Aging) (Eleanor Simonsick, Ph.D., 
Epidemiologist, Translational Gerontology Branch Reviewers); 
Discussion; Break; Title (Nigel Greig, Ph.D., Senior Investigator, 
Translational Gerontology Branch Reviewers); Discussion).
    Place: National Institutes of Health, Biomedical Research 
Center, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual 
Meeting).
    Closed: October 23, 2024, 11:30 a.m. to 1:30 p.m.
    Agenda: Drs. Mattison, Simonsick, and Greig meet individually 
and privately with BSC members; Executive Session Luncheon.
    Place: National Institutes of Health, Biomedical Research 
Center, 3A519/Virtual, 251 Bayview Boulevard, Baltimore, MD 21224 
(Virtual Meeting).
    Open: October 23, 2024, 1:30 p.m. to 2:30 p.m.
    Agenda: (Luigi Ferrucci, M.D., Senior Investigator, 
Translational Gerontology Branch Reviewers); Discussion.
    Place: National Institutes of Health, Biomedical Research 
Center, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual 
Meeting).
    Closed: October 23, 2024, 2:30 p.m. to 6:00 p.m.
    Agenda: Dr. Ferrucci meets individually and privately with BSC 
members; Break; Laboratory/Branch Leadership Overview (Rafael del 
Cabo, Ph.D., Laboratory Chief, Senior Investigator, Translational 
Gerontology Branch Discussion Leader); Discussion with the 
Laboratory/Branch Chief; Leadership Review Discussion; Break; BSC 
members to meet with Fellows from Laboratory of Behavioral 
Neuroscience; Executive Session; Adjourn.
    Place: National Institutes of Health, Biomedical Research 
Center, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual 
Meeting).
    Closed: October 24, 2024, 8:00 a.m. to 8:30 a.m.
    Agenda: Executive Session; Opening Remarks (Richard J. Hodes, 
M.D., NIA Director, and Luigi Ferrucci, M.D., Ph.D., Scientific 
Director, NIA); Board Business (Holly Brown-Borg, Ph.D., Acting 
Chairperson).
    Place: National Institutes of Health, Biomedical Research 
Center, 3C211/Virtual, 251 Bayview Boulevard, Baltimore, MD 21224 
(Virtual Meeting).
    Open: October 24, 2024, 8:30 a.m. to 10:15 a.m.
    Agenda: (AD Concept) (Luigi Ferrucci, M.D., Ph.D., Senior 
Investigator, Translational Gerontology Branch Reviewer); 
Discussion; (AD Concept) (Keenan Walker, Ph.D., NIH Distinguished 
Scholar, Tenure-track Investigator of Behavioral Neurosciences 
Reviewers); Discussion; (AD R&D Concept) (Mustapha Bouhrara, Ph.D., 
Earl Stadtman Tenure-Track Investigator, Laboratory of Clinical 
Investigator Reviewers); Discussion; Break.
    Place: National Institutes of Health, Biomedical Research 
Center, 251 Bayview Boulevard, Baltimore, MD 21224 (Virtual 
Meeting).
    Closed: October 24, 2024, 10:15 a.m. to 11:30 a.m.
    Agenda: Executive Session Luncheon; Adjourn.
    Place: National Institutes of Health, Biomedical Research 
Center, 3A519/Virtual, 251 Bayview Boulevard, Baltimore, MD 21224 
(Virtual Meeting).
    Contact Person: Luigi Ferrucci, M.D., Ph.D., Scientific 
Director, National Institute on Aging, 251 Bayview Boulevard, Suite 
100, Room 4C225, Baltimore, MD 21224, 410-558-8110, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging 
Research, National Institutes of Health, HHS)

    Dated: July 2, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-14968 Filed 7-8-24; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.